In this episode, Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the key HIV studies from CROI 2024 that are influencing their clinical practice, including: __ __ __ ____ Presenters: JOSEPH J. ERON, JR., MD Professor of Medicine, School of Medicine Herman and Louise Smith Distinguished Professor Chief, Division of Infectious Diseases Director, Clinical Core, UNC Center for AIDS Research Adjunct Professor of Epidemiology Gillings School of Global Public Health University of North Carolina at Chapel Hill Chapel Hill, North Carolina MONICA GANDHI, MD, MPH Professor of Medicine Division of HIV, Infectious Diseases, and Global Medicine Medical Director, Ward 86 HIV Clinic University of California, San Francisco San Francisco, California Content based on an online CME program supported by independent educational grants from Gilead Sciences; Merck & Co., Inc.; and ViiV Healthcare. Link to full program: https://bit.ly/4awdWJM
In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: __ __ Presenters: MARK S. SULKOWSKI, MD, FIDSA, FAASLD Professor of Medicine Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center Johns Hopkins University School of Medicine Baltimore, Maryland TATYANA KUSHNER, MD, MSCE Associate Professor Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York, New York PAUL Y. KWO, MD Professor of Medicine Director of Hepatology Stanford University School of Medicine Palo Alto, California JACKI CHEN, PHD Patient Advocate Link to full program: https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4a60GM4 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
In this episode, Robert Wong, MD, MS, and a patient discuss opportunities to optimize care for people living with hepatitis B virus (HBV), including: __ __ PRESENTER: ROBERT WONG, MD, MS Clinical Associate Professor Division of Gastroenterology and Hepatology Stanford University School of Medicine Palo Alto, California Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc. Link to full program: https://bit.ly/49TuZ8U Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify
Listen to Roger Bedimo, MD, MS, FACP, discuss considerations for older people living with HIV, including: __ __ Presenter: ROGER BEDIMO, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern Medical Center Chief, Infectious Diseases Section VA North Texas Health Care System Dallas, Texas Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. To download the slides: https://bit.ly/49zrnZs To view the full online program: https://bit.ly/49x0W6D
In this episode, Dr. Bedimo discusses best practices for individualized care in transgender women living with HIV, including: __ __ Presenter: ROGER BEDIMO, MD, MS, FACP Professor of Medicine Interim Director, Office of Global Health UT Southwestern Medical Center Chief, Infectious Diseases Section VA North Texas Health Care System Dallas, Texas Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. To download the slides: https://bit.ly/49zrnZs To view the full online program: https://bit.ly/49x0W6D
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss how to optimize the use of COVID-19 antivirals and how to navigate drug-drug interactions between COVID-19 treatments and a patient’s home medications. Their discussion includes: __ __ PRESENTERS: Renslow Sherer, MD Director International HIV Training Center Professor of Medicine Section of Infectious Diseases and Global Health Department of Medicine University of Chicago Chicago, Illinois Trinh P. Vu, PharmD, BCIDP Clinical Pharmacy Specialist in Infectious Diseases Department of Pharmaceutical Services Emory University Hospital Midtown Atlanta, Georgia Slideset: https://bit.ly/4c6kwbJ Downloadable resource: https://bit.ly/49rofP6 Full program: https://bit.ly/3P16TR8
In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including: __ __ ____ Presenter: NANCY REAU, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Rush University Medical Center Chicago, Illinois Link to full program: https://bit.ly/47XJlU4
In this episode, LaRon E. Nelson, PhD, RN, FNP, FNAP, FNYAM, FAAN, discusses the role that healthcare professionals (HCPs) may be playing in their patients’ pre-exposure prophylaxis (PrEP) persistence and strategies to modify their approach to encourage persistence, from Clinical Care Options (CCO), including: __ __ FACULTY LARON E. NELSON, PHD, RN, FNP, FNAP, FNYAM, FAAN Independence Foundation Professor School of Nursing Yale University New Haven, Connecticut FOLLOW ALONG WITH THE SLIDES: https://bit.ly/497cahK https://bit.ly/497cahK LINK TO FULL PROGRAM: https://bit.ly/3ZlICsL
In this episode, Nancy Reau, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus and hepatitis delta virus, including: __ __ PRESENTER: NANCY REAU, MD Professor of Medicine Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Richard B. Capps Chair of Hepatology Rush University Medical Center Chicago, Illinois Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc. Link to full program: BIT.LY/3SRMUGO https://bit.ly/3SrMuGO Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
In this episode, David Saunders discusses the value of nonstigmatizing discussions between people using HIV pre-exposure prophylaxis (PrEP) and healthcare professionals, including: __ __ FACULTY: DAVID SAUNDERS PrEP User and Advocate LINK TO FULL PROGRAM: https://bit.ly/3ZlICsL To automatically get new episodes as soon as they launch, subscribe to the CCO Infectious Disease podcast.
In this episode, Sarah M. Wood, MD, MS, discusses data and recommendations for long-acting pre-exposure prophylaxis (PrEP) as a strategy to support PrEP persistence and engagement for adolescents, including: __ __ FACULTY SARAH M. WOOD, MD, MS Assistant Professor of Pediatrics Division of Adolescent Medicine Perelman School of Medicine University of Pennsylvania Children’s Hospital of Philadelphia Philadelphia, Pennsylvania FOLLOW ALONG WITH THE SLIDES: https://bit.ly/3Ha9Kmt LINK TO FULL PROGRAM: https://bit.ly/3ZlICsL To automatically get new episodes as soon as they launch, subscribe to the CCO Infectious Disease podcast show.
In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: __ __ FACULTY: ANGELA BRANCHE, MD Associate Professor of Medicine Division of Infectious Diseases Department of Medicine University of Rochester Rochester, New York Link to full program: https://bit.ly/3nb25xe Link to downloadable slides: https://bit.ly/3TsXym5
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: __ __ Presenters: DOUGLAS DIETERICH, MD Director, Institute for Liver Medicine Professor of Medicine Division of Liver Diseases Mount Sinai School of Medicine New York, New York CAMILLA S. GRAHAM, MD, MPH Co-Director, Viral Hepatitis Clinic Division of Infectious Diseases Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts ROBERT WONG, MD, MS Clinical Associate Professor Division of Gastroenterology and Hepatology Stanford University School of Medicine Palo Alto, California Link to full program: https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4atS42z
In this episode, Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP, and Anne Teitelman, PhD, FNP-BC, FANNP, FAAN, discuss key PrEP considerations for advanced practice providers in primary care settings, including: __ __ FACULTY TAVELL L. KINDALL, PHD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP Director, HIV Prevention and Treatment St. Thomas Community Health Center New Orleans, Louisiana ANNE TEITELMAN, PHD, FNP-BC, FANNP, FAAN Associate Professor Emeritus of Nursing and Global Women’s Health Department of Family and Community Health School of Nursing University of Pennsylvania Professor Thomas Jefferson University College of Nursing Philadelphia, Pennsylvania LINK TO FULL PROGRAM: https://bit.ly/3PZGYdR
In this podcast episode, Mark Brennan-Ing, PhD, and Nina I. Martinez discuss mental health challenges in people living with HIV and much-needed strategies to overcome these challenges to optimize engagement in HIV care, including: __ __ PRESENTER: MARK BRENNAN-ING, PHD Director of Research and Evaluation Brookdale Center for Healthy Aging Hunter College The City University of New York New York, New York NINA I. MARTINEZ Public Health Consultant Link to full program: https://bit.ly/3TqVnl1
In this podcast episode, Isolde Butler, MD, MPH, a healthcare professional caring for people living with HIV, and Marissa Gonzalez, an individual living with HIV, discuss strategies to improve healthcare professionals’ competencies in delivering optimal HIV care from the start to better support patients in overcoming barriers to sustained care engagement. The topics they discuss include: __ __ PRESENTERS: ISOLDE F. BUTLER, MD, MPH Chief Medical Officer Cresentcare New Orleans, Louisiana MARISSA GONZALEZ Chair Community Advisory Board The Well Project Link to full program: https://bit.ly/3TqVnl1
In this podcast episode, Babafemi Taiwo, MBBS, and Vincent Crisostomo discuss the evolving treatment landscape for aging people living with HIV, encompassing the clinical and external resources necessary to support physical and psychosocial health. The topics discussed include: • Mindful prescribing and understanding the impact an HIV diagnosis can have on one’s mental health, including social isolation • How to address patients’ needs and establish a trusting relationship within the confines of a 15-minute clinic visit • How research is helping healthcare professionals better understand this clinical situation and discover opportunities to equalize metrics • The critical role of social workers and community organizations in patients’ overall care • Accessing federal HIV disability resources • Informed patient–provider discussion and counseling on medical decision-making regarding ART • How healthcare professionals can move toward clinical practice that leaves no one behind Presenter: BABAFEMI TAIWO, MBBS Gene Stollerman Professor of Medicine Chief Division of Infectious Diseases Northwestern University Feinberg School of Medicine Chicago, Illinois VINCENT CRISOSTOMO Director Aging Services San Francisco AIDS Foundation San Francisco, California Link to full program: https://bit.ly/3TqVnl1
In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: __ __ FACULTY KEVIN ASTLE, PHARMD, BCPS, BCACP, AAHIVP, CDCES Assistant Professor Pharmacotherapeutics and Clinical Research University of South Florida Taneja College of Medicine Tampa, Florida FOLLOW ALONG WITH THE SLIDES: bit.ly/48cULUN https://bit.ly/48cULUN LINK TO FULL PROGRAM: bit.ly/3ZlICsL https://bit.ly/3ZlICsL
During the 2023 American Association for the Study of Liver Diseases conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-δ agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and a fibrate. In this episode, Kris V. Kowdley MD, FAASLD, FACP, FACG, discusses topline results from several of these studies and more, including: __ __ PRESENTER: KRIS V. KOWDLEY MD, FAASLD, FACP, FACG Professor, Elson S. Floyd College of Medicine Washington State University Director, Liver Institute Northwest Seattle, Washington Link to reviews of other PBC studies from AASLD 2023: https://bit.ly/3RvXXEI
In this episode, Dr Tavell Kindall and Jona Tanguay discuss actionable strategies for advanced practice providers to increase the frequency at which PrEP is offered and initiated in primary care settings. Topics covered include: __ __ FACULTY: TAVELL L. KINDALL, PHD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP Director, HIV Prevention and Treatment St. Thomas Community Health Center New Orleans, Louisiana JONA TANGUAY, MMSC, PA-C, AAHIVS Medical Program Lead - Substance Use Disorders at Whitman-Walker Health Associate Medical Director - Transgender Health at Amida Care President-Elect at GLMA: Health Professionals Advancing LGBTQ+ Equality Clinical Instructor at Yale School of Medicine Founder at ChemsexHarmReduction.org https://chemsexharmreduction.org/ Washington, DC Content is supported by independent educational grants from Gilead Sciences, Inc. and ViiV Healthcare. Link to full program: https://bit.ly/3PZGYdR
In this third of 3 episodes, global HIV experts and advocates discuss the current status of HIV cure research, including key concepts to understand and communicate when counselling patients, colleagues, and the broader community on HIV cure: __ __ FACULTY: KATHARINE J. BAR, MD Associate Professor of Medicine Director, Penn CFAR Virus and Reservoirs Core University of Pennsylvania Philadelphia, Pennsylvania JENNIFER BLANCHETTE, PHD Independent Contractor Clinical Care Options Colorado, United States KRISTA L. DONG, MD Clinical Director, FRESH Cohort Assistant Professor of Medicine Massachusetts General Hospital Harvard Medical School Boston, Massachusetts KARINE DUBÉ, DRPH, MPHIL Associate Professor UCSD School of Medicine Division of Infectious Diseases and Global Public Health San Diego, California RICHARD JEFFERYS Basic Science, Vaccines & Cure Project Director Treatment Action Group New York, New York SHARON R. LEWIN, AO, FRACP, PHD, FAA, FAHMS Director Doherty Institute Melbourne Laureate Professor and Head Department of Infectious Diseases The University of Melbourne Consultant Physician Victorian Infectious Diseases Service Royal Melbourne Hospital Consultant Physician and Adjunct Professor Department of Infectious Diseases Alfred Hospital and Monash University Melbourne, Australia ANGELINA NAMIBA Founder Member 4M Network of Mentor Mothers London, United Kingdom LINK TO FULL PROGRAM: https://bit.ly/3QFwv7n
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including: __ __ FACULTY: JULIE ANN JUSTO, PHARMD, MS, FIDSA, BCPS Clinical Pharmacist Lead – Infectious Diseases Inpatient Pharmacy Dartmouth Hitchcock Medical Center Lebanon, New Hampshire Link to full program: https://bit.ly/41a8Mj0 Link to downloadable infographic: https://bit.ly/3t7NpT2
During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and a fibrate. In this episode, Stuart C. Gordon, MD, FAASLD, discusses topline results from one of these late-breaking studies and more, including: __ __ PRESENTER: STUART C. GORDON, MD, FAASLD Director of Hepatology Henry Ford Health System Professor of Medicine Wayne State University School of Medicine Detroit, Michigan Link to commentary: https://bit.ly/3GzRMt2 Link to reviews of other PBC studies from AASLD 2023: https://bit.ly/3RvXXEI
In this episode, Errol L. Fields, MD, PhD, MPH, and Armonté Butler, MPH, a pre-exposure prophylaxis (PrEP) advocate, discuss strategies for overcoming barriers to uptake of PrEP for HIV in adolescents and young adults, based on the unique needs of this patient population. Topics covered include: __ __ FACULTY: ERROL L. FIELDS, MD, PHD, MPH Associate Professor of Pediatrics Division of Adolescent/Young Adult Medicine Department of Pediatrics Johns Hopkins School of Medicine Baltimore, Maryland ARMONTÉ BUTLER, MPH Associate Director, LGBTQ Health & Rights Advocates for Youth Washington, DC Content is supported by independent educational grants from Gilead Sciences, Inc. and ViiV Healthcare. LINK TO FULL PROGRAM: https://bit.ly/3PZGYdR
During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and a fibrate. In this episode, Marlyn J. Mayo, MD, discusses topline results from several of these studies and more, including: __ __ Presenter: Marlyn J. Mayo, MD Professor of Internal Medicine Division of Digestive & Liver Diseases UT Southwestern Medical Center Dallas, Texas Link to commentary: COMING SOON! Link to reviews of other PBC studies from AASLD 2023: https://bit.ly/3RvXXEI
In this episode, Martin Rios discusses how pre-exposure prophylaxis (PrEP) persistence depends on healthcare professional knowledge, including: __ __ FACULTY: MARTIN RIOS PrEP User and Advocate Philadelphia, Pennsylvania LINK TO FULL PROGRAM: https://bit.ly/3ZlICsL
In this episode, Meredith Clement, MD, and Whitney C. Irie, MSW, PhD, discuss key considerations for pre-exposure prophylaxis (PrEP) uptake in cisgender women, including: __ __ FACULTY MEREDITH CLEMENT, MD Associate Professor Infectious Diseases Louisiana State University Health Sciences Center New Orleans, Louisiana WHITNEY C. IRIE, MSW, PHD Assistant Professor Department of Social Work Boston College Brighton, Massachusetts LINK TO FULL PROGRAM: https://bit.ly/3PZGYdR
In this episode, Helen Y. Chu, MD, MPH, shares updates on RSV seasonality, including: __ __ FACULTY: HELEN Y. CHU, MD, MPH Associate Professor of Medicine Division of Allergy & Infectious Diseases University of Washington School of Medicine Seattle, Washington Link to full program: https://bit.ly/3nb25xe Link to downloadable slides: https://bit.ly/3TsXym5
In this episode, Rick Zimmerman, MD, MPH, FAAFP, discusses RSV vaccines in older adults, including: __ __ FACULTY: RICHARD ZIMMERMAN, MD, MPH, FAAFP Professor Department of Family Medicine and Clinical Epidemiology University of Pittsburgh Pittsburgh, Pennsylvania Content based on an online CME program supported by an independent educational grant from GlaxoSmithKline. Link to full program: https://bit.ly/49YBZ4r Link to downloadable slides: https://bit.ly/3GocjRe
In this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Richard Zimmerman, MD, MPH, FAAFP, discuss the clinical presentation of RSV in older adults and available diagnostic tests for RSV, including: __ __ PROGRAM DIRECTOR: PAMELA ROCKWELL, DO, FAAFP Professor Family Medicine University of Michigan Medical School Ann Arbor, Michigan FACULTY: ANGELA BRANCHE, MD Associate Professor of Medicine Division of Infectious Diseases Department of Medicine University of Rochester Rochester, New York RICHARD ZIMMERMAN, MD, MPH, FAAFP Professor Department of Family Medicine and Clinical Epidemiology University of Pittsburgh Pittsburgh, Pennsylvania Content based on an online CME program supported by an independent educational grant from GlaxoSmithKline. Link to full program: https://bit.ly/49YBZ4r Link to downloadable slides: https://bit.ly/3GocjRe